Phase I Study of Alternate-Week Administration of Tipifarnib in Patients With Myelodysplastic Syndrome

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-1532
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Retrospective Evaluation of Patients With Myelodysplastic Syndrome

Experimental Biomedical Research
2019English

A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Phase I Trial of SAR103168, a Novel Multi-Kinase Inhibitor, in Patients With Refractory/Relapsed Acute Leukemia or High-Risk Myelodysplastic Syndrome

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Leukemia Research
Cancer ResearchOncologyHematology
2013English

Elderly Gastric Cancer Patients With Myelodysplastic Syndrome

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2018English

Patterns of Blood Product Use Among Patients With Myelodysplastic Syndrome

Vox Sanguinis
MedicineHematology
2011English

Prognostic Markers of Efficiency of Immunosupressive Therapy in Patients With Myelodysplastic Syndrome

ScienceRise
2015English

A Phase I Study of Tipifarnib Combined With Conventional Induction and Consolidation Therapy for Previously Untreated Patients With Acute Myeloid Leukemia Aged 60 Years and Over

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy